Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 22:34:10 GMT 2025
by
admin
on
Tue Apr 01 22:34:10 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
71RR81V666
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C129819
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
510615
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
||
|
NCI_THESAURUS |
C1511
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10856
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
PRIMARY | |||
|
C2527
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
PRIMARY | |||
|
100000181369
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
PRIMARY | |||
|
71RR81V666
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
PRIMARY | |||
|
HI-44
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
PRIMARY | |||
|
2097132-02-8
Created by
admin on Tue Apr 01 22:34:10 GMT 2025 , Edited by admin on Tue Apr 01 22:34:10 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_148 | 1_203 |
| 1_259 | 1_319 |
| 1_365 | 1_423 |
| 1_225 | 2_225 |
| 1_228 | 2_228 |
| 1_230 | 2_230 |
| 1_223 | 3_218 |
| 2_22 | 2_96 |
| 2_148 | 2_203 |
| 2_259 | 2_319 |
| 2_365 | 2_423 |
| 2_223 | 4_218 |
| 3_23 | 3_92 |
| 3_138 | 3_198 |
| 4_23 | 4_92 |
| 4_138 | 4_198 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_295 |
| N | 2_295 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->RADIOLIGAND |
|
||
|
NON-LABELED -> LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
immunomodulator, antineoplastic
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| RADIOLABEL | RESIDUE_SPECIFIC | Tyrosine |
Amount:
|
IOTYROSINE I-131 | Q1M94GA18P |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|